mAb Process Development and Optimization

31. Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit 3/13/2026

    See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.

32. Cell Line Selection In Novel Protein Therapeutic Development 9/13/2024

    Lena Tholen, Ph.D., and Meinhard Hasslacher, Ph.D., weigh in early on important cell line selection considerations for novel protein therapeutics in this segment of "Early Process Considerations For Novel Protein Therapeutics".

33. Cytovance Customer Testimonial: Thermo Scientific Single-Use Technologies 12/8/2020

    Thermo Fisher Scientific has served as a key partner in the bioprocess industry, by establishing manufacturing and development capabilities, enabling Cytovance Biologics to expand offerings their product offering, to better serve clients with diverse pharmaceutical needs. In this video, the imPULSE Single-Use Mixer is highlighted for protein refolding applications at a 30 L scale and then transferred to manufacturing operations up to 5,000 L scale.

34. Development Of A CHO Medium And Feed System Using Advanced Analytical Tools And Workflow Considerations 6/16/2025

    Discover how multiomics analysis and optimized formulations in a new cell culture medium deliver higher protein titers and specific productivity for CHO fed-batch systems.

35. Dry Powder Media Manufacturing Grand Island Expansion 11/5/2025

    Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

36. Applying AI And Rapid Prototyping To Media And Process Development 3/26/2026

    Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.

37. Why AstraZeneca and AbbVie Are Intensifying Processes 8/27/2024

    In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, our speakers share the motivation for continued process intensification in their respective organizations.

38. Manufacturing Friendly Aggregate Clearance In Downstream Processing 5/19/2025

    In this webinar, results are shared from the evaluation and preliminary optimization of a mixed-mode chromatography unit operation designed for aggregate removal in flow-through mode using a high-throughput POROS resin with immobilized caprylic acid.

39. Bioprocessing Solutions For Cell Culture 6/16/2025

    Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.

40. Cell Culture Media Manufacturing, Paisley, Scotland 11/4/2025

    Learn more about our cell culture media manufacturing global network, including details of the Paisley, Scotland site's capacity expansion supporting the bioprocessing industry's rapidly growing needs.